Medi-Span Resources

Advising patients on cannabis use can be challenging for clinicians – while it’s legal or approved for medical use in many U.S. states, because it’s illegal at the federal level, there’s lack of clinical standards and knowledge about interactions.

As news about COVID-19 changes every day and the world awaits the distant promise of a vaccine, healthcare workers are now focused on the daily realities of treating the disease. This is, like everything else about the pandemic, an informational moving target. Every day there are new ideas, new evidence, old possibilities are disproved, and clinicians and researchers in trenches share the benefit of their experiences.

The recently held National Community Pharmacists Association (NCPA) Annual Meeting provided an upbeat picture of community pharmacies trying to meet continuing pricing pressures by focusing on value-based services.

Results released last month from the 2019 J.D. Power U.S. Pharmacy Satisfaction Study showed that patients enjoy visiting brick-and-mortar pharmacies and find a great deal of satisfaction from talking with their pharmacist. More specifically, nearly 90% of patients surveyed in the annual report said they communicate with the pharmacist and staff in-person.